Author Archives: Jason Carr
Zogenix (ZGNX) Receives a Buy from Needham
In a report released today, Serge Belanger from Needham maintained a Buy rating on Zogenix (ZGNX – Research Report), with a price target of $58.00. The company’s shares closed last Monday at $47.11. According to TipRanks.com, Belanger is a 3-star
Needham Sticks to Their Buy Rating for Gamida Cell (GMDA)
Needham analyst Chad Messer maintained a Buy rating on Gamida Cell (GMDA – Research Report) today and set a price target of $19.00. The company’s shares closed last Monday at $4.67, close to its 52-week low of $2.93. According to
Chardan Capital Keeps Their Buy Rating on Editas Medicine (EDIT)
In a report released today, Geulah Livshits from Chardan Capital reiterated a Buy rating on Editas Medicine (EDIT – Research Report), with a price target of $55.00. The company’s shares closed last Monday at $30.32, close to its 52-week high
B.Riley FBR Keeps a Buy Rating on Ciena (CIEN)
B.Riley FBR analyst Dave Kang maintained a Buy rating on Ciena (CIEN – Research Report) today and set a price target of $56.00. The company’s shares closed last Monday at $34.61. According to TipRanks.com, Kang is a 5-star analyst with
H.C. Wainwright Sticks to Their Buy Rating for Americas Silver (USAS)
H.C. Wainwright analyst Heiko Ihle reiterated a Buy rating on Americas Silver (USAS – Research Report) today and set a price target of $4.50. The company’s shares closed last Monday at $2.90. According to TipRanks.com, Ihle ‘s ranking currently consits
Viper Energy (VNOM) Gets a Buy Rating from Barclays
Barclays analyst William S. Thompson maintained a Buy rating on Viper Energy (VNOM – Research Report) yesterday and set a price target of $34.00. The company’s shares closed last Monday at $24.91. According to TipRanks.com, Thompson ‘s ranking currently consits
